We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Gene Silencing Determines Eventual Stem Cell Fate

By LabMedica International staff writers
Posted on 23 Oct 2017
Print article
Sequestration of certain portions of the genome in close proximity to the wall of the nucleus in a stem cell determines whether genes in this region (the nuclear lamina) are expressed, which controls future cellular identity and function.

Progenitor stem cells differentiate into specialized cell types through coordinated expression of lineage-specific genes and modification of complex chromatin configurations. Investigators at the University of Pennsylvania (Philadelphia, USA) worked with heart stem cells to study the mechanism that causes certain areas of the genome to become bound to the nuclear membrane and the ramifications of being bound in this location.

The investigators reported in the October 12, 2017, online edition of the journal Cell that a histone deacetylase (Hdac3) protein organized heterochromatin at the nuclear lamina during cardiac progenitor lineage restriction. Hdac3 tethered peripheral heterochromatin containing lineage-relevant genes to the nuclear lamina. Deletion of Hdac3 in cardiac progenitor cells released genomic regions from the nuclear periphery, leading to precocious cardiac gene expression and differentiation into cardiomyocytes; in contrast, restricting Hdac3 to the nuclear periphery rescued myogenesis - allowing continued reproduction as stem cells - in progenitors otherwise lacking Hdac3.

This data demonstrated that nuclear lamina-chromatin interactions influenced cardiac progenitor cell differentiation. The investigators proposed that organogenesis was achieved through dynamic spatial reorganization of chromatin, including coordinated sequestration and/or release of genomic regions harboring key developmental genes from the nuclear lamina.

"The basis of this study is understanding the ability of a cell to respond to molecular cues to correctly become one cell type or another," said senior author, Dr. Rajan Jain, assistant professor of cardiovascular medicine at the University of Pennsylvania. "We wanted to know how that is achieved, step by step, because stem cells, capable of becoming any cell type in the body, give rise to cardiac muscle cells. Our work suggests that a cell defines its identity by storing away in an inaccessible closet the critical genes and programs necessary for it to mature into another cell type. In other words, a cell is "who" it is because it has silenced "who" it is not. We asked: Does this choreographed control of DNA availability contribute to a cell becoming a certain type?"

Related Links:
University of Pennsylvania

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Sekisui Diagnostics UK Ltd.